IKNA
Price
$1.39
Change
-$0.06 (-4.14%)
Updated
Feb 21 closing price
Capitalization
67.08M
23 days until earnings call
KRYS
Price
$187.86
Change
+$5.24 (+2.87%)
Updated
Feb 21 closing price
Capitalization
5.41B
78 days until earnings call
Ad is loading...

IKNA vs KRYS

Header iconIKNA vs KRYS Comparison
Open Charts IKNA vs KRYSBanner chart's image
Ikena Oncology
Price$1.39
Change-$0.06 (-4.14%)
Volume$82.48K
Capitalization67.08M
Krystal Biotech
Price$187.86
Change+$5.24 (+2.87%)
Volume$293.6K
Capitalization5.41B
IKNA vs KRYS Comparison Chart
Loading...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKNA vs. KRYS commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKNA is a Buy and KRYS is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (IKNA: $1.48 vs. KRYS: $156.69)
Brand notoriety: IKNA and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKNA: 17% vs. KRYS: 153%
Market capitalization -- IKNA: $67.08M vs. KRYS: $5.41B
IKNA [@Biotechnology] is valued at $67.08M. KRYS’s [@Biotechnology] market capitalization is $5.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKNA’s FA Score shows that 1 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • IKNA’s FA Score: 1 green, 4 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, IKNA is a better buy in the long-term than KRYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKNA’s TA Score shows that 5 TA indicator(s) are bullish while KRYS’s TA Score has 5 bullish TA indicator(s).

  • IKNA’s TA Score: 5 bullish, 3 bearish.
  • KRYS’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than IKNA.

Price Growth

IKNA (@Biotechnology) experienced а +2.07% price change this week, while KRYS (@Biotechnology) price change was +4.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

IKNA is expected to report earnings on May 08, 2025.

KRYS is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($5.41B) has a higher market cap than IKNA($67.1M). KRYS YTD gains are higher at: 0.019 vs. IKNA (-9.756). KRYS has higher annual earnings (EBITDA): 181M vs. IKNA (-63.58M). KRYS has more cash in the bank: 588M vs. IKNA (138M). KRYS has less debt than IKNA: KRYS (7.48M) vs IKNA (8.39M). KRYS has higher revenues than IKNA: KRYS (242M) vs IKNA (659K).
IKNAKRYSIKNA / KRYS
Capitalization67.1M5.41B1%
EBITDA-63.58M181M-35%
Gain YTD-9.7560.019-50,948%
P/E RatioN/A62.62-
Revenue659K242M0%
Total Cash138M588M23%
Total Debt8.39M7.48M112%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
23
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IKNAKRYS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 6 days ago
73%
Momentum
ODDS (%)
Bullish Trend 6 days ago
84%
Bearish Trend 6 days ago
73%
MACD
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
86%
Bullish Trend 6 days ago
78%
Advances
ODDS (%)
Bullish Trend 28 days ago
84%
Bullish Trend 19 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 13 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
82%
Aroon
ODDS (%)
Bearish Trend 6 days ago
85%
Bullish Trend 6 days ago
75%
View a ticker or compare two or three
Ad is loading...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

IKNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been loosely correlated with VNDA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IKNA jumps, then VNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
-0.67%
VNDA - IKNA
37%
Loosely correlated
+0.90%
KRYS - IKNA
34%
Loosely correlated
+2.25%
SCPH - IKNA
30%
Poorly correlated
-1.09%
CHRS - IKNA
29%
Poorly correlated
-5.08%
SRRK - IKNA
29%
Poorly correlated
-0.32%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with CLDX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+2.25%
CLDX - KRYS
57%
Loosely correlated
-0.70%
ALT - KRYS
46%
Loosely correlated
+1.73%
BEAM - KRYS
44%
Loosely correlated
+3.36%
ACLX - KRYS
44%
Loosely correlated
-1.49%
RGNX - KRYS
42%
Loosely correlated
+3.84%
More